8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Can Thrombolysis Prevent Ischemic Heart Failure?

      review-article
      ,
      Cardiology
      S. Karger AG
      Thrombolysis, Congestive heart failure

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the present era of thrombolysis, congestive heart failure secondary to (sub)acute coronary artery obstruction can be reduced to a considerable extent or even avoided altogether. Evidence from several recent trials in humans, aimed at restoring perfusion of the jeopardized myocardium - and thus preserving normal ventricular function - is presented. It is clear that thrombolysis, provided it is instituted within 4 h of onset of symptoms in patients with a large area of the myocardium at risk, can prevent ischemic heart failure.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          978-3-8055-4929-5
          978-3-318-01863-9
          0008-6312
          1421-9751
          1988
          1988
          11 November 2008
          : 75
          : Suppl 1
          : 90-102
          Affiliations
          Thorax Center, University Hospital, Erasmus University, Rotterdam, and the Netherlands Interuniversity Institute, Utrecht, The Netherlands
          Article
          174448 Cardiology 1988;75:90–102
          10.1159/000174448
          3069220
          ea05cae1-af19-4707-8033-529f4d389e4d
          © 1988 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 13
          Categories
          Session II

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Congestive heart failure,Thrombolysis

          Comments

          Comment on this article